Moderna Inc. Stock Sheds 2.9%, Underperforms Peers

Dow Jones
09/24

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Moderna Inc. slid 2.9% to $25.79 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.9% to 22,573.47 and Dow Jones Industrial Average falling 0.2% to 46,292.78.

Moderna Inc. closed 62.1% short of its 52-week high of $67.96, which the company achieved on September 30th.

The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 1.4% to $176.58, Pfizer Inc. rose 0.4% to $24.13, and Gilead Sciences Inc. rose 1.70% to $114.40.

Trading volume totaled 8.9 million, compared to the 50-day average of 10.2 million.

Data source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

September 23, 2025 16:35 ET (20:35 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10